Sulfamides and their use as endothelin receptor antagonists | Patent Number 07094781

US 07094781 B2
Application Number10433041
Publication NumberUS 20040077670 A1
Pendency4 years, 8 months, 22 days
Filled DateDec 4, 2001
Priority DateDec 4, 2001
Publication DateApr 22, 2004
Expiration DateAug 22, 2018
Inventor/ApplicantsChristoph Boss
Thomas Weller
Walter Fischli
Thomas Weller
Martine Clozel
Christoph Boss
Martin Bolli
Walter Fischli
Martin Bolli
Martine Clozel
ExaminesRAO, DEEPAK R
Art Unit1624
Technology Center1600
Assignments
Actelion Pharmaceuticals
Current
Actelion PharmaceuticalsJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.